Navigation Links
PharmaNet Extends Expiration Time in its Tender Offer and Consent Solicitation
Date:6/29/2011

of a consent to amend the related indenture. The Offer is made solely pursuant to the Offer to Purchase. The Offer is not being made to holders of Notes in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction.

None of the Company, the Dealer Managers and Solicitation Agents, the Information Agent or any other person makes any recommendation as to whether holders of Notes should tender their Notes, and no one has been authorized to make such a recommendation.

Company Information and Forward Looking StatementsPharmaNet is a leading provider of integrated product development services and provides clinical development services, including consulting, Phase I and bioequivalency clinical studies, and Phase II, III and IV clinical development programs, to pharmaceutical, biotechnology, generic drug and medical device companies around the world.

This press release contains forward-looking statements which include, but are not limited to, any statement that may predict, forecast, indicate or imply future results, performance, achievements or events. Forward-looking statements are based upon management's current plans and beliefs or current estimates of future results or trends. These forward-looking statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties that may cause actual results to differ materially from trends, plans or expectations set forth in the forward-looking statements.

Given these risks and uncertainties, we urge you to read the tender offer materials completely and with the understanding that actual future results may be materially different from what we plan or expect. All of the forward-looking statements made in this press release, including statements related to the Offer, including the Expiration Time,
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmaNet Extends Consent Payment Deadline for Notes Tendered in Its Tender Offer and Consent Solicitation
2. PharmaNet Announces Tender Offer and Consent Solicitation
3. PharmaNet to Present More Than 20 Posters at the 2010 American Association of Pharmaceutical Scientists Annual Meeting
4. PharmaNet Development Group Experts to Share Insights at the 9th Annual Partnerships in Clinical Trials Conference in Vienna
5. PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
6. Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer
7. SEC Closes Investigation of PharmaNet Development Group and Recommends No Action
8. Christopher Brennan Joins PharmaNet Development Group as General Counsel
9. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
10. PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
11. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Varian Medical Systems today broke ground ... Lake City manufacturing facility and allow for the consolidation ... create 1,000 new full time jobs in the state ... home to hardworking people with immense engineering and technical ... success in the manufacturing of our state-of-the-art X-ray technology,” ...
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 ... market research report is available in its ... Market 2014-2018 http://www.reportlinker.com/p02316661/Global-Biodegradable-Packaging-Materials-Market-2014-2018.html ... Biodegradable materials are materials that are readily ... packaging differs from conventional non-degradable packaging in ...
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces that a ... catalogue: Global Chelating Agents Market 2014-2018 ... About Chelating Agent A chelating agent is a ... metal ions, thereby forming a metal-ion complex. It ... on chemical processes, formulations, and the environment by ...
(Date:8/27/2014)... 27, 2014 “We are honored to ... said Ven Thangaraj, CEO of Radiant Sage. “We are ... taking the imaging corelab market to a different level. ... research organizations to efficiently and effectively manage the massive ... to be analyzed and read by trained physicians. Being ...
Breaking Biology Technology:Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Global Biodegradable Packaging Materials Market 2014-2018 2Global Biodegradable Packaging Materials Market 2014-2018 3Global Biodegradable Packaging Materials Market 2014-2018 4Global Biodegradable Packaging Materials Market 2014-2018 5Global Biodegradable Packaging Materials Market 2014-2018 6Global Biodegradable Packaging Materials Market 2014-2018 7Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2
... Arpida Ltd.,(SWX: ARPN) announces today that it ... Food and Drug Administration (FDA) regarding its New ... of complicated,skin and skin structure infections (cSSSI). The ... the application for iclaprim in its current form ...
... six genome centres demonstrated the power of partnerships ... at the International Plant and Animal Genomics Conference ... researchers, funders and other international stakeholders enjoyed Canadian ... event. , "This Canadian reception was a truly ...
... Fla. --- Algae is a livid green giveaway of nutrient ... action in tiny particles that would turn different colors if ... health in the blood. , Now, University of Florida engineering ... a major hurdle to creating such "smart dust.",The feat, which ...
Cached Biology Technology:FDA Issues Complete Response Letter for Iclaprim 2Researchers: Molecular forklifts overcome obstacle to 'smart dust' 2Researchers: Molecular forklifts overcome obstacle to 'smart dust' 3
(Date:8/27/2014)... understanding the mysteries of the human genome was unveiled ... the most detailed comparison yet of how the genomes ... , The research, appearing August 28 in in the ... in the three species, genomes is "read out," and ... , The results add billions of entries to a ...
(Date:8/27/2014)... effective doses of the HIV drug maraviroc, a new ... completed before the drug was licensed in 2007, included ... key to removing maraviroc from the body. The current ... protein including nearly half of African-Americans end ... those who lack the protein even when given the ...
(Date:8/27/2014)... LAKE CITY, Aug. 27, 2014 University of Utah ... his native Turkey, has won that nation,s highest science ... of Science. , Sekercioglu is among five researchers picked ... and Technical Research Council of Turkey. Three researchers won ... won the Special Award, which is equivalent to the ...
Breaking Biology News(10 mins):Encyclopedia of how genomes function gets much bigger 2Encyclopedia of how genomes function gets much bigger 3Encyclopedia of how genomes function gets much bigger 4Dosage of HIV drug may be ineffective for half of African-Americans 2University of Utah biologist wins Turkey's top science prize 2
... - NOVEMBER 6, 2013: In an ... a New York-based physician-researcher from the Touro College of Osteopathic ... for levels of a growth protein that could help predict ... an analysis of findings in prior published studies, Touro researcher ...
... Mo. Researchers from the University of Missouri have ... cancer, the fourth leading cause of cancer death in ... deaths each year in the United States, and kills ... years, according to the National Cancer Institute. ...
... and largest of its kind study focusing on the ... in JAMA Pediatrics . The "Teen Longitudinal ... the National Institutes of Health (NIH) and is being ... Children,s Hospital. Thomas H. Inge, MD, PhD, with ...
Cached Biology News:Breastfeeding as a possible deterrent to autism -- a clinical perspective 2Breastfeeding as a possible deterrent to autism -- a clinical perspective 3MU study finds more accurate method to diagnose pancreatic cancer 2Findings announced from landmark study on safety of adolescent bariatric surgery 2
Mouse monoclonal to OCIL ( Abpromise for all tested applications)....
... antigen initiates replication from the ... the presence of the host ... be used in conjunction with ... cat. no. 8050. For ...
NuParaffin Kit Application: Flow Cytometry Reactivity: Human...
Request Info...
Biology Products: